Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.

Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update ...

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

26.79% of the stock is owned by institutional investors. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever INO has been the ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more ...

Stock market crash today: Infosys, SBI, Tata Steel, Asian Paints, JSW Steel, Bajaj Finserv, Bajaj Finance and Mahindra & Mahindra were the biggest laggards. People look at a screen displaying the ...

Stock Market Today: Domestic equity benchmarks Nifty 50 and Sensex extended losses for the third straight session after investors offloaded utility, capital goods and metal stocks amid foreign ...

Super Micro Computer (SMCI) shares slumped Monday morning as the stock feels the impact of a pair of headlines that came out after the bell Friday, including a potential capital raise and the ...

The company is also expected to present immunological data supporting INO-3107's mechanism of action at upcoming medical conferences. While these data are not anticipated to be major catalysts for the ...

The delay in BLA submission for INO-3107 due to manufacturing issues with the CELLECTRA device could significantly impact Inovio's market position. This concern is reflected in the stock's recent ...